Diabetes drug linked to increased bladder cancer risk

A new study of 145,806 people who took pioglitazone compared to other oral diabetes drugs showed that it raises the risk of bladder cancer by 63%. Results were published in the BMJ. NHS Direct
Source: Society for Endocrinology - Category: Endocrinology Source Type: news